Summary of Plexus Conference Call Company Overview - **Company**: Plexus - **Industry**: Electronic Manufacturing Services (EMS) - **Market Focus**: Healthcare life sciences, industrial, aerospace, and defense - **Company Size**: Approximately $4 billion in revenue - **Financial Goals**: Targeting annual revenue growth of 9%-12%, operating margin of 6% or greater (non-GAAP), and 15% return on invested capital [4][4][4] Core Insights and Arguments - **Market Dynamics**: - Plexus is experiencing a recovery from two years of flat growth, with positive trends in semiconductor capital equipment, healthcare, defense, and commercial space [11][12] - Commercial aerospace is still recovering, with expectations for future growth as Boeing and other aerospace companies ramp up production [12][12] - **Capacity Expansion**: - Recent investments include a new facility in Penang, Malaysia, which is expected to support up to $1 billion in revenue with a break-even point anticipated soon [19][19] - Expansion in Thailand is also underway, with rapid growth expected [19][19] - **Supply Chain Management**: - Plexus is focusing on regional production to shorten supply chains, with a strong presence in North America, Mexico, Asia, and Europe [27][27] - The company is actively managing component price fluctuations through a cost-plus model, ensuring that price increases are passed on to customers [58][58] - **Technological Investments**: - Investments in automation, such as the AutoStore unit, are expected to improve efficiency and margins [40][40] - AI is being deployed to enhance internal processes, including procurement and inventory management, leading to significant time savings [49][50] Additional Important Points - **Financial Performance**: - The company generated approximately $500 million in free cash flow over the past two fiscal years, with a target of $100 million in free cash flow for fiscal 2026 [101][101] - The cash cycle is being targeted to be in the mid-60s, with a current healthy balance sheet and a debt to EBITDA ratio below 1 [103][103] - **Shareholder Returns**: - Plexus has a $100 million share repurchase program, with $63 million remaining on the current authorization [117][117] - **Engineering Focus**: - Engineering is core to Plexus's operations, allowing for strong customer engagement and product development, particularly in aerospace and defense sectors [81][81][90] - **Growth Potential**: - The defense and unmanned systems market has the potential to double by fiscal 2026, driven by early engagement in upcoming programs [74][74] - The industrial sector, particularly semiconductor capital equipment, is expected to benefit from increased spending and AI advancements [75][75] This summary encapsulates the key points discussed during the Plexus conference call, highlighting the company's strategic focus, market dynamics, and financial performance.

Group 1 - The announcement of early elections in Japan has led to increased volatility in the yen and Japanese government bond markets, but the core investment view remains unchanged [1] - The market generally expects the ruling Liberal Democratic Party to secure a majority without relying on coalition partners, despite rising speculation around the potential repeal of the consumption tax [1] - Japan's overall fiscal situation is relatively stable, with a budget deficit of only about 0.2% of GDP, significantly lower than most developed markets [1] Group 2 - Attractive investment opportunities may arise in sectors that could benefit from a stronger yen or potential consumption tax exemptions, including certain local consumer stocks [2] - High-quality export stocks with pricing power that can help mitigate adverse currency effects are also seen as defensive investments [2] - Selected investment opportunities are emerging in commodity-related, consumer, and financial sectors, with valuations still attractive relative to mid-term fundamental prospects [2]

Core Insights - China's new licensing requirements for rare earth metal exports are creating uncertainty in the semiconductor industry, particularly affecting chip equipment manufacturers [1][2] - Major companies like Applied Materials, Lam Research, and KLA Corp are identified as particularly vulnerable to supply chain disruptions and cost inflation due to their reliance on rare earth materials [2][4] Group 1: Applied Materials Inc (AMAT) - Applied Materials is heavily reliant on rare earths for its semiconductor capital equipment, particularly for maintaining ultra-clean vacuum environments [3] - The company could face delays in tool shipments or increased costs if sourcing becomes constrained due to China's export licensing regime [4] - Despite a 35% increase in stock year-to-date, potential supply chain risks may dampen investor enthusiasm moving into 2026 [4] Group 2: Lam Research Corp (LRCX) - Lam Research has seen a 90% surge in stock in 2025, but its dependence on rare earths for etching and deposition tools poses a risk [5] - The company’s production timelines could be affected by disruptions in rare earth supply, as China controls over 90% of global rare earth processing capacity [6] - Even minor supply chain issues could lead to significant volatility in LRCX shares, which are already priced for perfection [7] Group 3: KLA Corp (KLAC) - KLA's metrology and inspection systems require rare-earth-based magnets for precision, making it vulnerable to China's export restrictions [8] - The stock has increased over 60% this year, but reliance on rare earth-dependent components could complicate future product rollouts [9] - The timing of China's restrictions adds unpredictability, and investors may need to reassess valuations if supply chain risks materialize [9]

Financial Data and Key Metrics Changes - For Q4, the company reported approximately $8.3 billion in revenue, exceeding guidance by roughly $800 million, with core operating income at $519 million and a core operating margin of 6.3%, a 50 basis point improvement year-over-year [9][12][17] - Core diluted earnings per share was $3.29, while GAAP diluted earnings per share came in at $1.99 [9][12] - Full-year adjusted free cash flow exceeded $1.3 billion, with a debt-to-core EBITDA ratio of 1.3 times and cash balances of approximately $1.9 billion [12][13] Segment Performance Changes - Regulated Industries revenue was $3.1 billion, with a year-over-year increase of approximately 3% and a core operating margin of 6.5% [10] - Intelligent Infrastructure revenue reached $3.7 billion, $400 million above expectations, with a core operating margin of 5.9% [10][11] - Connected Living and Digital Commerce revenue totaled $1.4 billion, reflecting a year-over-year decline of approximately 14%, but with a core operating margin of 6.6%, up 210 basis points year-over-year [11][12] Market Data and Key Metrics Changes - The automotive and transportation market is expected to decline by 5% in FY26, while healthcare outsourcing is entering a growth phase, particularly in drug delivery systems [49][50] - AI-related revenue is projected to grow by roughly 25% in FY26, reaching about $11.2 billion, driven by strong demand in cloud and data center infrastructure [53][54] Company Strategy and Industry Competition - The company is focusing on system-level integration across its segments, particularly in Intelligent Infrastructure, to enhance speed and reduce costs for customers [51][52] - A deliberate shift is being made in Connected Living and Digital Commerce to exit lower-margin programs while investing in higher-margin opportunities [55][56] - The company aims to maintain a disciplined capital allocation strategy, returning approximately 80% of free cash flow to shareholders [57] Management's Comments on Operating Environment and Future Outlook - Management highlighted the resilience of the diversified portfolio despite mixed market dynamics, with strong performance in AI-related sectors offsetting weaknesses in automotive and renewables [35][36] - The company is well-positioned for sustainable growth, targeting 6% plus core operating margins and over $1.5 billion in adjusted free cash flow over time [57][58] Other Important Information - The company completed a $1 billion share repurchase authorization and has a new $1 billion program authorized for FY26 [14][15] - The company is investing in AI and automation across its operations to enhance efficiency and competitiveness [39][43] Q&A Session Summary Question: Can you provide details on growth areas in AI? - The company expects 25% year-on-year growth in AI revenue, with significant growth in capital equipment and cloud and data center infrastructure, while maintaining strong positions in existing markets [64][65] Question: What is the outlook for healthcare growth? - Growth is anticipated in drug delivery systems and devices, with a healthy pipeline of new business awarded, contributing to margin expansion [66]